Drug Shortage Report for SODIUM THIOSULFATE INJECTION USP
Report ID | 163673 |
Drug Identification Number | 02428393 |
Brand name | SODIUM THIOSULFATE INJECTION USP |
Common or Proper name | Sodium Thiosulfate Injection USP |
Company Name | HOPE PHARMACEUTICALS LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM THIOSULFATE |
Strength(s) | 250MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 x 50 mL Vials |
ATC code | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-06-29 |
Estimated end date | |
Actual end date | 2022-09-30 |
Shortage status | Resolved |
Updated date | 2022-10-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 422 RICHARDS STREET VANCOUVER, BRITISH COLUMBIA CANADA V6B 2Z4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-10-11 | French | Compare |
v7 | 2022-10-11 | French | Compare |
v6 | 2022-10-11 | English | Compare |
v5 | 2022-06-30 | English | Compare |
v4 | 2022-06-29 | English | Compare |
v3 | 2022-06-29 | French | Compare |
v2 | 2022-06-29 | English | Compare |
v1 | 2022-06-29 | English | Compare |
Showing 1 to 8 of 8